| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are booster doses of poliovirus vaccine necessary?
|
Salk, Jonas
|
|
1990
|
8 |
5 |
p. 419-420
2 p.
|
artikel
|
| 2 |
Bordetella bronchiseptica vaccine; comprises whole B. bronchiseptica cells obtained from liquid culture and inactivated with glutaraldehyde
|
|
|
1990
|
8 |
5 |
p. 511-
1 p.
|
artikel
|
| 3 |
Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice
|
Bosseray, Nicole
|
|
1990
|
8 |
5 |
p. 462-468
7 p.
|
artikel
|
| 4 |
Characteristics of inactivated hepatitis A vaccine prepared from virus propagated in heteroploid continuous monkey cell line
|
Kusov, Yu.Yu.
|
|
1990
|
8 |
5 |
p. 513-514
2 p.
|
artikel
|
| 5 |
Composition containing DNA sequence encoding protein vaccine; eliciting antibody recognizing Treponema hyodysenteriae antigen
|
|
|
1990
|
8 |
5 |
p. 510-
1 p.
|
artikel
|
| 6 |
Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses
|
Nerome, Kuniaki
|
|
1990
|
8 |
5 |
p. 503-509
7 p.
|
artikel
|
| 7 |
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
|
Murphy, Brian R.
|
|
1990
|
8 |
5 |
p. 497-502
6 p.
|
artikel
|
| 8 |
Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines
|
Clemens, John D.
|
|
1990
|
8 |
5 |
p. 469-472
4 p.
|
artikel
|
| 9 |
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis
|
Wild, Fabian
|
|
1990
|
8 |
5 |
p. 441-442
2 p.
|
artikel
|
| 10 |
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
|
Tamura, Shin-ichi
|
|
1990
|
8 |
5 |
p. 479-485
7 p.
|
artikel
|
| 11 |
Fusion protein containing Escherichia coli and/or Shigella dysenteriae outer membrane protein-A and human influenza haemagglutinin, useful as vaccine; cell expressing it useful as live vaccine
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 12 |
Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies)
|
Kit, Saul
|
|
1990
|
8 |
5 |
p. 420-424
5 p.
|
artikel
|
| 13 |
Genetics and Pathogenicity of Negative Strand Viruses
|
Spier, R.E.
|
|
1990
|
8 |
5 |
p. 515-
1 p.
|
artikel
|
| 14 |
Haemophilus influenzae pilus vaccine is used for protection against infection and to prevent transmission to and colonization of upper respiratory tract
|
|
|
1990
|
8 |
5 |
p. 510-511
2 p.
|
artikel
|
| 15 |
Infectious-bursal-disease-virus (IBDV) vaccine for fowl; contains IBDV antigen material from mammal cell culture infected with IBDV
|
|
|
1990
|
8 |
5 |
p. 511-
1 p.
|
artikel
|
| 16 |
International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them
|
Doel, T.R.
|
|
1990
|
8 |
5 |
p. 473-478
6 p.
|
artikel
|
| 17 |
Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects
|
Fescharek, Reinhard
|
|
1990
|
8 |
5 |
p. 446-456
11 p.
|
artikel
|
| 18 |
Modified Bordetella pertussis toxin gene; inactive protein application in pertussis vaccine preparation
|
|
|
1990
|
8 |
5 |
p. 510-
1 p.
|
artikel
|
| 19 |
Modifying wild strain entero-invasive Shigella; genome transformation to prevent cell invasion, spreading or toxin production; enterchelin, aerobactin and/or Shiga toxin gene deletion; vaccine production
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 20 |
Mycobacterium expressing antigen from a pathogen; carried on a mycobacterial-bacterial hybrid vector or a lysogenizing vector; Mycobacterium smegmatis and Mycobacterium bovis used for recombinant vaccine production
|
|
|
1990
|
8 |
5 |
p. 511-
1 p.
|
artikel
|
| 21 |
New antigenic protein derived from nonA,nonB hepatitis virus is useful in vaccine and diagnosis, and related antisera and DNA fragments; DNA sequence and DNA probe
|
|
|
1990
|
8 |
5 |
p. 510-
1 p.
|
artikel
|
| 22 |
Newcastle-disease virus strain NDW CNCM I-781; fowl live vaccine
|
|
|
1990
|
8 |
5 |
p. 510-
1 p.
|
artikel
|
| 23 |
New Neisseria mutants unable to induce production of blocking antibody; Neisseria gonorrhoeae and Neisseria meningitidis lacking gene for protein PIII, useful in production of protective antigen for vaccine
|
|
|
1990
|
8 |
5 |
p. 510-
1 p.
|
artikel
|
| 24 |
New plasmid containing complete cDNA of human rhino virus-2; plasmid pHRV 2/1 vector construction; potential vaccine construction; protein engineering
|
|
|
1990
|
8 |
5 |
p. 511-
1 p.
|
artikel
|
| 25 |
Polio immunity to killed vaccine: an 18-year follow-up
|
Böttiger, Margareta
|
|
1990
|
8 |
5 |
p. 443-445
3 p.
|
artikel
|
| 26 |
Poliomyelitis serosurveillance and immunization for elderly people in otherwise efficiently immunized areas
|
Arya, S.C.
|
|
1990
|
8 |
5 |
p. 514-
1 p.
|
artikel
|
| 27 |
Potential use of live viral and bacterial vectors for vaccines
|
|
|
1990
|
8 |
5 |
p. 425-436
12 p.
|
artikel
|
| 28 |
Production of bluetongue virus non-structural proteins; NS1 protein gene cloning and expression in Spodoptera frugiperda cell culture; potential application in recombinant vaccine construction and diagnosis
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 29 |
Production of stable avirulent mutants of Legionella pneumophila for use as legionellosis vaccine and antigen targeting vector
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 30 |
Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins
|
Cook, R.F.
|
|
1990
|
8 |
5 |
p. 491-496
6 p.
|
artikel
|
| 31 |
Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein
|
Agterberg, Marja
|
|
1990
|
8 |
5 |
p. 438-440
3 p.
|
artikel
|
| 32 |
Pseudomonas aeruginosa outer membrane lipoprotein; recombinant vaccine construction; outer membrane protein-I gene cloning and expression in Escherichia coli; monoclonal antibody preparation and hybridoma construction
|
|
|
1990
|
8 |
5 |
p. 511-512
2 p.
|
artikel
|
| 33 |
Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses
|
Ogawa, Ryohei
|
|
1990
|
8 |
5 |
p. 486-490
5 p.
|
artikel
|
| 34 |
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial
|
Storsaeter, Jann
|
|
1990
|
8 |
5 |
p. 457-461
5 p.
|
artikel
|
| 35 |
Transformed salmonella bacterial strains; malaria recombinant vaccine construction; circumsporozoite antigen gene cloning and constitutive expression in attenuated Salmonella typhimurium, Salmonella dublin or Salmonella typhi
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 36 |
Universal vaccine for protecting pigs against Haemophilus pleuropneumoniae; toxin purification by ammonium sulphate precipitation and dialysis
|
|
|
1990
|
8 |
5 |
p. 512-
1 p.
|
artikel
|
| 37 |
Vaccination Strategies of Tropical Diseases
|
Spier, R.E.
|
|
1990
|
8 |
5 |
p. 514-515
2 p.
|
artikel
|
Tijdschrift beschrijving